An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

In this section: Education and Training

Women's Health Events

From the FDA Office of Women's Health

FDA’s Office of Women’s Health (OWH) is pleased to present a series of educational webinars on a broad range of topics to promote, protect, and advance the health of women. These webinars target the needs of researchers, healthcare professionals, and students. Watch this space for new events in 2025!

Sub-Topic Paragraphs

Sickle Cell Disease: A Spotlight on Women

This webinar discussed the clinical characteristics of sickle cell disease (SCD), advances in medical therapies to treat SCD, and the unique factors impacting women living with SCD.

Image of sexually transmitted infections

Sexually Transmitted Infections in Women

This webinar reviewed the epidemiology, clinical presentation, diagnostic approach, and treatment of the common and curable sexually transmitted infections in women.

Hyperemesis Gravidarum: New Research and Insights

This webinar reviewed the latest research on maternal, fetal, and child adverse outcomes for the most severe form of nausea and vomiting caused by pregnancy, hyperemesis gravidarum. CME/CNE/CPE available.

Bringing Clinical Research to Patients

This webinar focused on decentralized clinical trials and other novel strategies currently available for bringing clinical research to patients. CME/CNE/CPE available.

Menopause: Potential Impact on Clinical Pharmacology

Speakers discussed the current understanding of the impact of menopause on the pharmacokinetics and pharmacodynamics, and exposure-response relationships of FDA-regulated drugs and biologics used by menopausal women for non-menopause-related indications

PCOS Revisited: Diagnosis, Management, and Future Needs

This webinar reviewed the pathophysiology, diagnosis, comorbidities, and findings from recent research on Polycystic Ovary Syndrome.

More previous events

OWH offers recordings of previous events on a variety of women’s health topics, including CE for health professionals for some events.

OWH continuing education (CE)

OWH offers recordings of previous events for continuing education credit.

U.S. Food and Drug Administration

Women's Health Events

From the FDA Office of Women's Health

Previous events